The active treatment displayed tendencies toward prolonging the duration before the initial exacerbation and reducing the frequency of exacerbations, although these outcomes did not reach statistical significance.
← all excerpts
Ciprofloxacin-Loaded Inhalable Formulations against Lower Respiratory Tract Infections: Challenges, Recent Advances, and Future Perspectives.
1
—
—